Clear Street’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History
Bought
Maintained
Sold
Other funds holding TDACW
Clear Street's TDACW Position: Q2 2026 in Review
Clear Street reduced its Translational Development Acquisition Corp Warrants (TDACW) stake by 46% in Q2 2026, selling an estimated $75.7K and leaving 89,393 shares worth $127K. The position accounts for ﹤0.01% of the portfolio, ranked #794.
Clear Street first reported a position in TDACW in Q1 2025 and has held it in 6 quarters since. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.
- Clear Street held 89,393 shares of Translational Development Acquisition Corp Warrants worth $127K as of Q2 2026.
- Clear Street sold 75,415 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $75.7K.
- Translational Development Acquisition Corp Warrants made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #794 holding.
- Clear Street first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 6 quarters since.
- 28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.
Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.